Related Experiment Video
Updated: Aug 26, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam
Claudio Viscoli1, Marco Machetti, Paola Cappellano
1Infectious Disease Unit, National Institute for Cancer Research and University of Genoa, Genoa, Italy. viscolic@unige.it
Abstract:
At the bone marrow transplantation center of the San Martino Hospital (Genoa), we observed an increase in the rate of patients with positive Platelia Aspergillus (PA; Bio-Rad) test results, from 10% (38 of 386 patients) in the period from January 1999 through January 2003 to 36% (21 of 59 patients) in the period from February 2003 through May 2003. Positivity was significantly (P<.001) associated with the administration of piperacillin-tazobactam (PT) (17 [74%] of 23 patients who received PT had positive results vs. 4 [11%] of 36 who did not receive PT). Multivariate analysis found administration of PT ( chi 2=34.7; P<.001) and underlying disease ( chi 2=21.14; P<.001) to be associated with PA positivity. Of 15 PT batches tested, 12 had positive PA test results.
Insights
A rise in positive Aspergillus tests in bone marrow transplant patients was linked to piperacillin-tazobactam (PT). Further investigation revealed contamination in several PT batches, suggesting a potential source of false positives.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Hematology
Background:
- The Platelia Aspergillus (PA) test is crucial for diagnosing invasive aspergillosis in immunocompromised patients.
- An increase in PA test positivity was observed at a bone marrow transplantation center.
Purpose of the Study:
- To investigate the reasons behind the increased rate of positive Platelia Aspergillus test results.
- To determine the association between piperacillin-tazobactam administration and PA test positivity.
Main Methods:
- Retrospective analysis of PA test results in bone marrow transplant patients.
- Statistical analysis to assess the association between piperacillin-tazobactam and PA positivity.
- Testing of piperacillin-tazobactam batches for Aspergillus contamination.
Main Results:
- PA test positivity increased from 10% to 36% within a specific period.
- Piperacillin-tazobactam (PT) administration was significantly associated with positive PA test results (74% vs. 11%).
- 12 out of 15 tested PT batches showed positive results for Aspergillus.
Conclusions:
- Piperacillin-tazobactam administration is strongly associated with false-positive Platelia Aspergillus test results.
- Contamination within piperacillin-tazobactam batches is a likely cause of the observed increase in PA positivity.
- Clinical laboratories and transplant centers should be aware of this potential issue when interpreting PA test results in patients receiving PT.
Related Concept Videos
Atypical Pneumonia
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...